510(k) Report

510(k) · Cleared

Cleared

Enterprise Electrophysiology System

K110967510(k) TraditionalCleared Jun 30, 201185-day reviewClass II21 CFR 882.1400

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Neuralynx, Inc. · OMC Reduced- Montage Standard Electroencephalograph

Cleared on Jun 30, 2011 as substantially equivalent to K060523 (Cyberkinetics, Inc., 2006) and 1 other predicate after an 85-day review. Its family tree reaches back 2 generations to 2005.

Decided
Jun 30, 2011
Review
85 days
Class
Class II
Product code
OMC
Recalls
None
Predicates
2

Its longest line of descent runs back 2 generations to K042626 (2005). No later device cites it as a predicate yet.

  1. Root · 2 generations backK042626 Neuroport Neural Signal Processor (NSP) SystemCyberkinetics, Inc. · 2005
  2. 1 generation backK060523 Neuroport Neural Signal Processing SystemCyberkinetics, Inc. · 2006
  3. This deviceK110967 Enterprise Electrophysiology SystemNeuralynx, Inc. · 2011
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K042626Neuroport Neural Signal Processor (NSP) SystemCyberkinetics, Inc.2005—
−1K060523Neuroport Neural Signal Processing SystemCyberkinetics, Inc.2006—
0 (this device)K110967Enterprise Electrophysiology SystemNeuralynx, Inc.2011—
FIG. 1 — Lineage of K110967, 2005–2011Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in OMC? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new OMC device

  1. #1 K251550 NX01 (NX01)score 13.1 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K060523Neuroport Neural Signal Processing System
Summary page 2
…)(3)] The Enterprise Electrophysiology System uses similar technology and has similar physical output characteristics as the following predicate device: k060523 NeuroPort System manufactured by Cyberkinetics Neurotechnology Systems. Parameters Neuralynx…
Cyberkinetics, Inc.2006—
*K042626Neuroport Neural Signal Processor (NSP) System
Summary page 5
…1. Conclusion [21 CFR 807.92(b)(3)] Technologically, the Enterprise System was found to be substantially equivalent to the currently cleared k060523/k042626 AfeuroPort manufactured by Cyberkinetics Neurotechnology Systems Inc. The indications for use are identical to the previo…
Cyberkinetics, Inc.2005—

Also cleared against K060523: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 6 years and passes through 2 companies; a new generation was cleared every 5.3 years on median.
  • None of the 2 ancestors has a recall.
  • 1 other device also cites its predicate K060523.

How does its category compare?

All OMC devices

OMC Reduced- Montage Standard Electroencephalograph: FDA decisions, review times, recalls and adverse event reports over 20 years. 2011, this device’s year, is highlighted.

FDA decisions per year · OMC

3in 2025

2010: 12011: 12012: 12013: 12014: 12015: 12017: 12019: 12020: 12021: 12022: 12023: 22024: 32025: 32026 (partial year): 1
2007high 3 (2024) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · OMC

172in 2025

2024: 56 days median2025: 172 days median
2007high 172 (2025) · low 56 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · OMC

No recall names OMC since 2007.

Adverse event reports per year · OMC

2in 2025

2023: 22024: 22025: 2
2007high 2 (2023) · low 0 (2007)2025

MAUDE reports naming product code OMC, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20101—00
20111—00
20121—00
20131—00
20141—00
20151—00
20160—00
20171—00
20180—00
20191—00
20201—00
20211—00
20221—00
20232—02
202435602
2025317202
20261—0—

What is it indicated for?

The intended use of the Neuralynx Enterprise Electrophysiology System is for temporary (<30 days) recording and monitoring of brain electrical activity.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K110967: Enterprise Electrophysiology System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K110967

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026